Skip to main content
. 2016 Aug;28(4):413–422. doi: 10.21147/j.issn.1000-9604.2016.04.04

1.

Patients' clinicopathological characteristics

Characteristics n (%) P
TT group (N=109) TA group (N=199)
TT, transthoracic; TA, transabdominal; BMI, body mass index; #, expressed as median (P25, P75); *, calculated by Chi-Square test; **, calculated by Mann-Whitney U test.
Gender 0.384*
Female 17 (15.6) 39 (19.6)
Male 92 (84.4) 160 (80.4)
Age (year)
<70 87 (79.8) 169 (84.9) 0.252*
≥70 22 (20.2) 30 (15.1)
BMI (kg/m2)# 21.6 (20.3, 23.0) 21.3 (20.3, 22.7) 0.705**
Macroscopic type 0.476*
0-2 84 (77.1) 146 (73.4)
3-4 25 (22.9) 53 (26.6)
Siewert type 0.034*
II 69 (63.3) 101 (50.8)
III 40 (36.7) 98 (49.2)
Tumor size (cm) 0.259**
0-5.0 8 (7.3) 18 (9.0)
5.1-8.0 54 (49.5) 108 (54.3)
>8 47 (43.1) 73 (36.7)
Histological grade 0.353*
Well & Moderate 31 (28.4) 47 (23.6)
Poor & Undifferentiated 78 (71.6) 152 (76.4)
T stage 0.054**
T1 4 (3.7) 12 (6.0)
T2 7 (6.4) 26 (13.1)
T3 2 (1.8) 3 (1.5)
T4 96 (88.1) 158 (79.4)
N stage 0.144**
N0 37 (33.9) 50 (25.1)
N1 22 (20.2) 51 (25.6)
N2 28 (25.7) 43 (21.6)
N3 21 (19.3) 55 (27.6)
TNM stage 0.614**
Ia 3 (2.8) 11 (5.5)
Ib 5 (4.6) 12 (6.0)
IIa 2 (1.8) 11 (5.5)
IIb 29 (26.6) 31 (15.6)
IIIa 20 (18.3) 42 (21.1)
IIIb 28 (25.7) 39 (19.6)
IIIc 22 (20.2) 53 (26.6)